![](/img/cover-not-exists.png)
Efficacy of oral triple upfront combination therapy (long-acting prostacyclin analogue, endothelin receptor antagonist, phosphodiesterase 5 inhibitor) in the patients with idiopathic/heritable pulmonary arterial hypertension
Ogo, Takeshi, Fukui, Shigefumi, Tsuji, Akihiro, Nakanishi, NorifumiVolume:
93
Language:
english
Journal:
Life Sciences
DOI:
10.1016/j.lfs.2013.12.168
Date:
December, 2013
File:
PDF, 99 KB
english, 2013